How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PB

OOTC:PBLA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

PB

Panbela Therapeutics IncOOTC PBLA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

OOTC - OTC

FAIR VALUE

Is PBLA undervalued compared to its fair value?

The fair value of PBLA stock is hidden USD. Relative to the market price of 0.34 USD Panbela Therapeutics Inc is hidden.

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. The company is headquartered in Waconia, Minnesota and currently employs 6 full-time employees. The company went IPO ...[More about valuation]

Panbela Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.002 $B

Price:

0.34 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-2.691

FINANCIALS

Panbela Therapeutics financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0078 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0078 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.011 B
-0.0025 B

Financial Position Analysis

Assets

0.011 B
Current Assets
0.0019 B
Total non-current assets
0.0087 B

Total current liabilities
0.0089 B
Total non-current liabilities
0.0042 B

Cash Flow Statement

-0.0067 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0067 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Panbela Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is PBLA attractive for investment based on fundamental analysis?

PBLA stock rating is hidden. Panbela Therapeutics is a hidden by Eyestock methodology.

Get PBLA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

PBLA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for PBLA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Panbela Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Panbela Therapeutics Inc dividends

PBLA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About PBLA stock

About the company Panbela Therapeutics Inc

Market cap $B

0.002

Dividend yield

Shares outstanding

14.5959 B

Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. The company is headquartered in Waconia, Minnesota and currently employs 6 full-time employees. The company went IPO on 2014-07-29. The firm is focused on developing disruptive therapeutics for the treatment of patients with cancer. Its primary focus is on the treatment of patients with pancreatic cancer. Its lead product candidate, SBP-101, is a polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma, ovarian cancer and other tumors. The firm is conducting Phase Ia/Ib study of the safety, tolerability and pharmacokinetics of SBP-101 when administered in combination with gemcitabine and nab-paclitaxel.

PBLA profile

  • Ticker

    PBLA

  • Country

    USA

  • Exchange

    OOTC - OTC

  • Report currency

    USD - US dollar

  • IPO date

    29 July 2014

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    6

  • City

    Waconia

  • Address

    712 Vista Blvd # 305

  • Cusip

    69833W206